Career history of Kenneth A. Tassey
Former positions of Kenneth A. Tassey
Companies | Position | Start | End |
---|---|---|---|
NANOMIX CORPORATION | Director/Board Member | 01/11/2010 | 30/06/2014 |
Chief Operating Officer | 01/11/2010 | 13/11/2012 | |
Founder | 24/08/2009 | 30/06/2014 | |
Investor Relations Contact | 01/11/2010 | 31/07/2012 | |
Public Communications Contact | 01/11/2010 | 31/07/2012 | |
President | 01/11/2010 | 30/06/2014 | |
Boston Therapeutics, Inc. /Old/ | Chief Executive Officer | 01/06/2009 | 01/11/2010 |
Founder | 01/06/2009 | 01/11/2010 | |
President | - | 01/11/2010 | |
LRN Corp.
LRN Corp. Miscellaneous Commercial ServicesCommercial Services LRN Corp. provides ethics and compliance knowledge solutions and advisory services. It offers integrated solutions, such as essential ethics and compliance, essential inspirational leadership, essential environmental and social responsibility, ethics and compliance management system, and education services. The company was founded by Dov L. Seidman in 1994 and is headquartered in Los Angeles, CA. | President | - | 01/03/2009 |
Statistics
International
United States | 4 |
Operational
President | 3 |
Founder | 2 |
Chief Executive Officer | 1 |
Sectoral
Health Technology | 3 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 3 |
---|---|
LRN Corp.
LRN Corp. Miscellaneous Commercial ServicesCommercial Services LRN Corp. provides ethics and compliance knowledge solutions and advisory services. It offers integrated solutions, such as essential ethics and compliance, essential inspirational leadership, essential environmental and social responsibility, ethics and compliance management system, and education services. The company was founded by Dov L. Seidman in 1994 and is headquartered in Los Angeles, CA. | Commercial Services |
Boston Therapeutics, Inc. /Old/ | Health Technology |
Boston Therapeutics, Inc.
Boston Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Boston Therapeutics, Inc. is a pharmaceutical company, which engages in the development, manufacture, and commercialization of novel compounds based on complex carbohydrate chemistry. Its products are designed to help manage blood sugar, treat pre-diabetes, and diabetes related pathologies. Its drug candidates comprises of BTI320, BTI-410, and IPOXYN. The company was founded by David Platt and Kenneth A. Tassey Jr. on August 24, 2009 and is headquartered in Lawrence, MA. | Health Technology |
- Stock Market
- Insiders
- Kenneth A. Tassey
- Experience